Introduction: Polycystic ovary syndrome (PCOS) is the most common endocrinopathyin women of reproductive age. It causes a metabolic syndrome characterized by insulin resistance, hyperinsulinemia, and dyslipidemia. Vitamin d deficiency and its association with PCOS still represents a controversial subject in the literature.
Introduction
Polycystic ovary syndrome (PCOS) is an endocrinopathy that affects 5 to 10% of women of reproductive age worldwide, being characterized by chronic anovulation, hyperandrogenism, and polycystic ovaries at ultrasound [1] . Therefore, it is a heterogeneous condition of androgen excess with different degrees of reproductive and metabolic dysfunctions [2, 3] .
Furthermore, this syndrome is associated with increased risk of infertility and cardiovascular diseases, affecting the quality of life of these women [4] . In this context, vitamin D presents an association with fertility, since its acting mechanism impacts on both reproductive cells and immune system cells [5] .
Vitamin d deficiency contributes to the PCOS development, thus promoting insulin resistance, which increases the risk of cardiovascular disease and type 2 diabetes mellitus. On the other hand, other authors state that women with PCOS may present a higher risk to develop vitamin d deficiency, not the opposite [6, 7] .
Vitamin d deficiency in women with PCOS is probably due to the obesity of patients with this pathology. Nevertheless, other studies have shown that vitamin d is related to glucose metabolism, through insulin regulation, because of changes in insulin receptor expression and cytokine suppression. Such process may be related to insulin resistance during vitamin d deficiency, consequently resulting in obesity [3, 4, 5, 6, 7, 8] .
In this perspective, there is no consensus in the literature regarding the pathophysiology of PCOS and vitamin d deficiency, including if there is a real distinction in serum vitamin d levels in women with and without this disease. Therefore, this study aims to understand the association between polycystic ovary syndrome and vitamin d deficiency, and how it occurs; thus, identifying if there is a difference in serum vitamin d levels in women with and without PCOS, and whether vitamin d deficiency causes or is related to insulin resistance in PCOS patients.
Methods
This is an integrative review study, as it aims to synthesize a subject, based on the survey of several related studies. The integrative review consists of six stages, starting by establishing the hypothesis or guiding question, followed by literature search, categorization of studies, evaluation of the studies included in the review, interpretation of the results, and synthesis of the knowledge or presentation of the review [9, 10] .
In the first stage of the review, the following guiding questions were designed: "Do women diagnosed with polycystic ovary syndrome present vitamin d deficiency when compared to women without this diagnosis?" and "How to establish the causal relationship between PCOS and vitamin d deficiency?"
Literature search took place in the National Library of Medicine and National Institute of Health (PubMed), Scopus, Latin American and Caribbean Health Sciences Literature (LILACS), and Cumulative Index to Nursing and Allied Health Literature (CINAHL) databases. Data collection occurred from August 2016 to January 2017, using the controlled descriptors "Polycystic Ovary Syndrome" and "Vitamin D", and the Boolean operator "AND"to combine the descriptors: ("Polycystic Ovary Syndrome") AND "Vitamin D".
Initial sample comprised 744 articles, of which 77 were identified in PubMed database, 23 in CINA-HL, 644 in Scopus, and none in LILACS. Next, the following inclusion criteria were applied to refine the search: original articles in the English, Portuguese, or Spanish languagesthat answered the guiding questions of the study and presented a detailed methodological description and consistent presentation of the results. Moreover, no filter restriction was established for the year of publication of the articles.
To identify the articles that best help to understandthe association between PCOS and serum vitamin d levels, a previous selection occurred, in which only the title of the article was read, followed by the abstract and then the full text. The final sample consisted of 7 articles: 2 from the PubMed database, 4 from Scopus, and 1 from CINAHL.
Selected studies were categorized and the necessary information was extracted, which were then organized and entered in a 712 publications were excluded: not presenting full-text articles; reflective studies; integrative reviews;duplicates; and not answering the study objective.
8 publications were excluded for not presenting a completely described methodology and not focusing the association between vitamin d deficiency in women with polycystic ovary syndrome. Results Table 1 presents the results of the publications regarding the identification, title, objectives, design, level of evidence, and the variables of interest of the review. The results showed an association between the VDR gene variants and PCOS risk. These data also indicated that the INSR "NN" genotype was a marker of decreased insulin in women with PCOS. However, further studies are needed to confirm the findings and elucidate the biological mechanisms by which these polymorphisms influence the PCOS risk. Regarding the year of publication, four articles (57.1%) were published in 2015; two (28.5%), in 2014; and one (14.2%), in 2009. All articles were in English. As for the methods, there were four (57.1%) with a cross-sectional design, two (28.5%) systematic reviews with meta-analysis, and one (14.2%) case-control.
Identification
Regarding the level of evidence, 28.5% presented level I; 14.2%, level III; and 57.1%, level IV. Level of evidence I represents strong evidence, in which at least one systematic review of many studies with a randomized controlled design can be identified. Level of evidence III indicates strong evidence of randomized study, time series, matched case-controls, among others. As for the level of evidence IV, itshows non-experimental studies that present a good delineation and that take place in more than one research site [18] .
Rotterdam criteria were used as diagnostic reference for the polycystic ovary syndrome in five (71.4%) of the studies. As to the research site, two studies (28.5%) took place in Iran and one (14.2%) in Korea, the other studies did not mention it. Regarding the sample size, three studies (42.8%) comprised less than 100 patients; and only two (28.5%), more than 200. Another important aspect worth highlighting is that four studies (57.1%) included women with PCOS and control groups (without PCOS) for comparison.
Conducted a systematic review with metaanalysis that showed that vitamin d concentration in PCOS patients is lower than in women without PCOS, thus suggesting that vitamin d concentration was negatively associated with insulin resistance in PCOS, but failed to detect the effect of vitamin D3 supplementation on PCOS [11] .
A study of 2014, however, identified that the difference in the 25(OH)D concentration among women with and without PCOS was not statistically significant. In addition, serum vitamin d levels have no correlation with insulin resistance. Corroborating this research, Kim et al [13] did not verify differences between serum vitamin d levels in women with and without PCOS; it also found no relationship between the 25(OH)D concentration and the hormonal and metabolic profile of these patients [12] .
Performed a cross-sectional study with 206 women diagnosed with PCOS and did not identify any difference in these patients regarding vitamin d concentration, nor in vitamin d levels with total testosterone and free testosterone [19] .
Conducted a research to investigate, among other genes, the association of polymorphisms in the vitamin d receptor (VDR) and the risk of developing polycystic ovary syndrome. They found that the gene variants responsible for the VDR may be used to indicate susceptibility to PCOS, but further studies are needed to determine how these polymorphisms influence the PCOS risk [12] .
Found that women of reproductive age are at high risk for vitamin d deficiency in a global context, thus not identifying a direct association between PCOS and vitamin d levels [14] .
A systematic review to determine whether serum vitamin d levels are lower in women with PCOS than in women without PCOS and concluded that vitamin d deficiency is common among PCOS patients. Nonetheless, there is no scientific evidence to prove that this vitamin deficiency is associated with the development of polycystic ovary syndrome, but rather that vitamin d deficiency is probably one of the consequences of PCOS [17] .
Discussion
The prevalence of vitamin d deficiency in women with PCOS is still uncertain, and serum 25(OH)D levels in women with this syndrome, portrayed in some studies, are still inconsistent [20] . This data corroborates those found by this research, since the existing studies on this subject are still very inconclusive.
Studies show the association between vitamin d and fertility, so it may be related to the outco-me of some pathologies, such as endometriosis and polycystic ovary syndrome. Nonetheless, the pathophysiology of PCOS usually presents hyperinsulinemia and obesity, which represent disorders of the endocrine system. Therefore, insulin resistance is common in PCOS, not being caused by vitamin d deficiency as some of the studies surveyed in the review suggest [21] .
Unlike these findings, the National Health and Nutrition Program identified an association between serum 25(OH)D levels and the development of the metabolic syndrome. It also states that the vitamin d concentration is inversely related to the risk of hyperglycemia and insulin resistance [22] .
Women with PCOS are more susceptible to severe complications, which include insulin resistance, hyperinsulinemia, and dyslipidemia. With calcium and vitamin d supplementation for eight weeks, PCOS patients presented a significant change in insulin concentration [3] .
Study found that obese women with PCOS had lower vitamin d levels than non-obese women with PCOS, and that 25(OH)D deficiency was related to the development of insulin resistance in these patients, thus impairing their glucose tolerance [23] .
A systematic review concluded that the association between vitamin d and metabolic disorders in women with PCOS remains obscure. Although the literature reports an inverse relationship between vitamin d levels and insulin resistance in PCOS patients, these studies are still very heterogeneous, hencehindering a conclusion [24] .
On the other hand, other studies already investigatethe effect of calcium and vitamin d supplementation in women with PCOS, noting that this therapy improves the hormonal environment and sequelae related to the syndrome. Nevertheless, it also suggests the need for further studies to better understand these benefits [25] .
That the variety of phenotypes of PCOS patients and the heterogeneity of available studies make it difficult to draw conclusions and suggest the conduction of clinical trials with well-defined populations [26] .
Conclusions
It is noticed that, despite the great amount of studies conducted on t he subject, there is not a single conclusion that is shared between authors, quite the contrary, some are even contradictory. Therefore, it is concluded that vitamin d levels in PCOS patients remain a controversial subject, in which some authors argue that there is no difference between vitamin d levels in women with and without PCOS, as well as this vitamin deficiency is not related to insulin resistance.
In this context, it is imperative to wait for further studies with higher levels of evidence to understand how the association between polycystic ovary syndrome and vitamin d deficiency occurs and to clarify doubts in order to provide a more qualified and targeted assistance. 
